Latest News and Press Releases

Longeveron selected as a Semi-Finalist Team and one of the Top 40 Teams receiving a $250,000 Milestone 1 Award in the XPRIZE Healthspan competition.

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Royalty Rates in Pharmaceutical and Biotechnology Deals 2010-2025" has been added to ResearchAndMarkets.com's offering.This report contains a...

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Collaboration Deals in Biotechnology 2019-2025" report has been added to ResearchAndMarkets.com's offering.Collaboration Deals in Biotechnology...

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2025" has been added to ResearchAndMarkets.com's offering.This report contains a...

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025" report has been added to ResearchAndMarkets.com's offering. The...

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering.The report contains a...

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025" has been added to ResearchAndMarkets.com's offering.This report contains a...

Longeveron announces Q1 2025 financial results & provides business update. Pivotal Phase 2 clinical trial achieves 95% enrollment. Expected full enroll Q2.

Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research & production of cell-based pharmaceuticals – developed based on artificial platelet technology...

Eascra Biotech announced their first commercial lab, a preclinical startup space within the Massachusetts Biomedical Initiatives facility in Worcester, MA.